Drug Database
Back to search

Netherlands· NL-1eed0a9a70f2

Synacthen 0,25 mg/ml, oplossing voor injectie of infusie

A tetracosactide product containing tetracosactide, registered in Netherlands by Alfasigma S.p.A.. The same ATC class is registered in 10 of our 19 countries.

ATC H01AA02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedSynacthen 0,25 mg/ml, oplossing voor …ATCH01AA02REGISTER NO.NL-1eed0a9a70f2PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about tetracosactideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Tetracosactide is registered in 10 of 19 countries.

Countries holding a registration under ATC H01AA02 (tetracosactide), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose
Search tetracosactide products by name

Tetracosactide · ATC H01AA02

10 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Franceprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
TETRACOSACTIDE
Manufacturer
Alfasigma S.p.A.
Country
Netherlands (NL)
ATC code
H01AA02
ATC class
Tetracosactide
Defined daily dose
0.25 mg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    05082

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

295 interactions on record for tetracosactide.

Graded by severity as the source publishes them — 29 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check tetracosactide against other medicinesHow interaction checks work

Tetracosactide · interactions on record

295 records

  • 29 severe
  • 246 moderate
  • 20 minor

Most severe, free to view

  • DesirudinB01AE01severe
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate
  • Liquid paraffinA06AA01moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tetracosactide in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tetracosactide products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Austria · Synacthen Ampulle, Synacthen Depot
  • Belgium · Synacthen, Synacthen Depot
  • Denmark · Synacthen
  • France · Synacthene, Synacthene Retard
  • Ireland · Synacthen
  • Italy · Synacthen
  • Luxembourg · Synacthen, Synacthen Dépôt
  • Sweden · Synacthen, Synacthen Depot

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/2c3c0ab8-ee8b-435f-b7af-179baa759170
GET /v1/drugs/2c3c0ab8-ee8b-435f-b7af-179baa759170?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Oplossing voor injectie of infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h05082_smpc.pdf",
  "strength": null,
  "atc_label": "Tetracosactide",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg05082",
  "excipients": [
    "AZIJNZUUR (E 260), GECONCENTREERD",
    "NATRIUMACETAAT 3-WATER (E 262)",
    "NATRIUMCHLORIDE",
    "WATER, GEZUIVERD"
  ],
  "substances": [
    "TETRACOSACTIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h05082.pdf",
  "authorised_at": "1966/05/18",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "05082",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about tetracosactide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console